Delivery Order SPE2DB22D2206-SPE2DB25FHD83
Award Date
5/28/25
Potential Completion Date
6/18/25
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products. The contract, valued at $4,687.18, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products. The contract, valued at $2,343.59, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price delivery order with a performance period through June 12, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 6, 2024, with a ceiling value of $7,030.77 and a completion date of December 30, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, to the U.S. Defense Logistics Agency (DLA). The award was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order with a ceiling value of $4,530.60 and a performance period through May 2, 2024. This award is associated with a...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products to the U.S. Defense Logistics Agency (DLA). The $4,530.60 fixed-price delivery order was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 8, 2024. The contract has an ultimate completion date of July 29, 2024 and was not set aside for a specific business type. Amerisourcebergen holds a single-award Indefinite Delivery...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products to the Defense Logistics Agency (DLA). The $7,030.77 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 26, 2025, with a completion date of March 19, 2025. The contract is a delivery order under an Indefinite Delivery Contract valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award, issued by the Defense Logistics Agency (DLA), provides for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty pharmaceutical product. The $4,530.60 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 4, 2024. The award has an ultimate completion date of June 26, 2024 and is not associated with any set-aside requirements. This delivery order is part of AmerisourceBergen's broader...
This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML SYRING 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,780.96 and is a firm fixed-price delivery order with a completion date of June 8, 2023. The contract is not designated as a set-aside and was awarded through full and open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,687.18 firm-fixed-price delivery order is for the supply of the medication TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a period of performance through June 5, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
The federal contract award summarized is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Medical Supply Chain. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 18, 2024 with a ceiling value of $2,343.59. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 10, 2025. There was no set-aside designation for this...